| RLAY Market Cap History Table | ||||||||||||||||||||||||||||||||||
Also see: RLAY Shares Outstanding History and RLAY YTD Return |
| RLAY Market Cap History Chart | |||||||||||||||||||||||||||||||||||
-17.69% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||
| RLAY Stock Price Chart |
| About Relay Therapeutics Inc |
| Relay Therapeutics is a clinical-stage precision medicines company. Co. has deployed its technology platform to build a pipeline of product candidates to address targets in precision medicine where there is clear evidence linking target proteins to disease and where molecular diagnostics can identify relevant patients for treatment. Co. has initiated a clinical trial for one of its product candidates, RLY-4008, an oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2) for patients with advanced or metastatic FGFR2-altered solid tumors. The U.S. Food and Drug Administration has granted orphan drug designation to RLY-4008 for the treatment of cholangiocarcinoma. We show 16 historical shares outstanding datapoints in our RLAY shares outstanding history coverage, used to compute RLAY market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing RLAY market cap history over the course of time is important for investors interested in comparing RLAY's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of RLAY versus a peer is one thing; comparing RLAY market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like RLAY can fluctuate over the course of history. With this page we aim to empower investors researching RLAY by allowing them to research the RLAY market cap history. |
| RLAY Current Stock Quote |
 Free RLAY Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| RLAY Share Performance |
| Market Cap Peers |
| Relay Therapeutics (RLAY) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
RLMD Market Cap History |
